MedComm | Plasma pTau181 as a biomarker for Alzheimer's disease


Open the phone and scan

Alzheimer's disease (AD) is one of the most difficult neurological disorders, because there are no means of biomarkers to predict the disease progression, nor is there a cure. Recently, on Nature Medicine, Thijssen et al and Janelidze et al reported an advanced diagnostic biomarker, plasma pTau181, for Alzheimer's disease.

Fig. 1 The potential of plasma tau as Alzheimer's disease (AD) biomarker.




Article Access:




Website for MedComm:

Looking forward to your contributions.